View Item 

Show simple item record

Evaluation of a Weight‐based Rabbit Anti‐thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients
dc.contributor.authorPennington, Catherine A.en_US
dc.contributor.authorTischer, Sarah M.en_US
dc.contributor.authorLee, Elizaen_US
dc.contributor.authorLee, Sunen_US
dc.contributor.authorSindelar, Jamesen_US
dc.contributor.authorPark, Jeong M.en_US
dc.date.accessioned2015-09-01T19:30:56Z
dc.date.available2016-09-06T15:43:59Zen
dc.date.issued2015-08en_US
dc.identifier.citationPennington, Catherine A.; Tischer, Sarah M.; Lee, Eliza; Lee, Sun; Sindelar, James; Park, Jeong M. (2015). "Evaluation of a Weight‐based Rabbit Anti‐thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy (8): 748-754.en_US
dc.identifier.issn0277-0008en_US
dc.identifier.issn1875-9114en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/113166
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherrabbit anti‐thymocyte globulinen_US
dc.subject.otheracute rejectionen_US
dc.subject.otherinductionen_US
dc.subject.otherkidney transplantationen_US
dc.subject.othercosten_US
dc.titleEvaluation of a Weight‐based Rabbit Anti‐thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipientsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/113166/1/phar1624.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/113166/2/phar1624_am.pdf
dc.identifier.doi10.1002/phar.1624en_US
dc.identifier.sourcePharmacotherapy: The Journal of Human Pharmacology and Drug Therapyen_US
dc.identifier.citedreferenceMourad G, Garrigue V, Squifflet JP, et al. Induction versus no induction in renal transplant recipients with tacrolimus‐based immunosuppression. Transplantation 2001; 71: 1050 – 5.en_US
dc.identifier.citedreferenceBrennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D, Thymoglobulin induction study group. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 2006; 355: 1967 – 77.en_US
dc.identifier.citedreferenceSolez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753 – 60.en_US
dc.identifier.citedreferenceTsapepas DS, Mohan S, Tanriover B, et al. Impact of small variations in the delivered dose of rabbit antithymocyte globulin induction therapy in kidney transplantation with early steroid withdrawal. Transplantation 2012; 94: 325 – 30.en_US
dc.identifier.citedreferenceKlem P, Cooper JE, Weiss AS, et al. Reduced dose rabbit anti‐thymocyte globulin induction for prevention of acute rejection in high‐risk kidney transplant. Transplantation 2009; 88: 891 – 6.en_US
dc.identifier.citedreferenceGurk‐Turner C, Airee R, Philosophe B, Kukuruga D, Drachenberg C, Haririan A. Thymoglobulin dose optimization for induction therapy in high risk kidney transplant recipients. Transplantation 2008; 85: 1425 – 30.en_US
dc.identifier.citedreferenceAgha IA, Rueda J, Alvarez A, et al. Short course induction immunosuppression with Thymoglobulin for renal transplant recipients. Transplantation 2002; 73: 473 – 5.en_US
dc.identifier.citedreferenceScientific registry of transplant recipients (SRTR) annual report. Available from http://www.srtr.org/annual_reports/2011/506a_ki.aspx. Accessed August 11, 2014.en_US
dc.identifier.citedreferenceBrennan DC, Flavin K, Lowell JA, et al. A randomized, double‐blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation 1999; 67: 1011 – 8.en_US
dc.identifier.citedreferenceNicolleto BB, Fonseca NKO, Manfro R, et al. Effects of obesity on kidney transplantation outcomes: a systematic review and meta‐analysis. Transplantation 2014; 98: 167 – 76.en_US
dc.identifier.citedreferenceCurran SP, Famure O, Li Y, Kim SJ. Increased recipient body mass index is associated with acute rejection and other adverse outcomes after kidney transplantation. Transplantation 2014; 97: 64 – 70.en_US
dc.identifier.citedreferenceGore JL, Pham PT, Danovitch GM, et al. Obesity and outcome following renal transplantation. Am J Transplant 2006; 6: 357 – 63.en_US
dc.identifier.citedreferenceHeinbokel T, Floerchinger B, Schmiderer A, et al. Obesity and its impact on transplantation and alloimmunity. Transplantation 2013; 96: 10 – 6.en_US
dc.identifier.citedreferenceRed Book Online [database online]. Greenwood Village, CO: Truven Health Analytics, Inc. Updated periodically. Accessed August 11, 2014.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
phar1624.pdf
Size:
261.8KB
Format:
PDF
View/Open
Name:
phar1624_am.pdf
Size:
586.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.